Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (51.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (31.6%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- products for consumption by the general public (17%): OTC drugs, ophthalmological products (world's No. 1 producer of soft contact lenses; Acuvue brand), nutritional products, personal care products (RoC, Neutrogena brands, etc.), feminine hygiene and baby care products, etc.

At the end of 2019, Johnson & Johnson has 97 manufacturing facilities located in the United States (32), North America (11), Europe (27), Africa and Asia/Pacific (27).

Net sales break down geographically as follows: the United States (51.3%), North America (7.2%), Europe (22.5%), Asia/Pacific and Africa (19%).

Number of employees : 134 500 people.
Sales per Business
20192020Delta
Pharmaceutical42 198.0051.4%45 572.0055.2% +8%
Medical Devices25 963.0031.6%22 959.0027.8% -11.57%
Consumer13 898.0016.9%14 053.0017% +1.12%
USD in Million
Sales per region
20192020Delta
United States42 097.0051.3%43 133.0052.2% +2.46%
Europe18 466.0022.5%18 980.0023% +2.78%
Asia-Pacific, Africa15 555.0018.9%15 136.0018.3% -2.69%
Western Hemisphere Excluding United States5 941.007.2%5 335.006.5% -10.2%
USD in Million
Managers
Name Title Age Since
Joaquin Duato Chief Executive Officer & Director 59 2022
Joseph Wolk Chief Financial Officer & Executive Vice President 54 2018
James Swanson Global Chief Information Officer & Executive VP - 2019
Charles O. Prince Independent Director 71 2006
Anne M. Mulcahy Lead Independent Director 68 2012
Ronald Williams Independent Director 71 2011
Ian Davis Independent Non-Executive Director 70 2010
A. Eugene Washington, Dr. Independent Director 70 2012
Mark B. McClellan, Dr. Independent Director 57 2013
D. Davis Independent Director 69 2014
Members of the board
Name Title Age Since
Alex Gorsky Executive Chairman 61 2022
Charles O. Prince Independent Director 71 2006
Anne M. Mulcahy Lead Independent Director 68 2012
Ronald Williams Independent Director 71 2011
Ian Davis Independent Non-Executive Director 70 2010
A. Eugene Washington, Dr. Independent Director 70 2012
Mark B. McClellan, Dr. Independent Director 57 2013
D. Davis Independent Director 69 2014
Mary C. Beckerle, Dr. Independent Director 66 2015
Joaquin Duato Chief Executive Officer & Director 59 2022
Shareholders
NameEquities%
The Vanguard Group, Inc. 222,696,341 8.46%
SSgA Funds Management, Inc. 142,185,280 5.40%
BlackRock Fund Advisors 58,949,348 2.24%
Geode Capital Management LLC 43,320,776 1.65%
Northern Trust Investments, Inc.(Investment Management) 34,963,887 1.33%
Capital Research & Management Co. 32,520,000 1.24%
Wellington Management Co. LLP 32,250,541 1.23%
State Farm Investment Management Corp. 31,675,492 1.20%
Norges Bank Investment Management 27,770,786 1.05%
Massachusetts Financial Services Co. 27,016,165 1.03%
Holdings
NameEquities%Valuation
ARGENX SE (ARGX) 1,766,899 3.47% 633,537,786 USD
IDORSIA LTD (IDIA) 9,581,882 5.41% 195,465,123 USD
BIOCARTIS GROUP NV (BCART) 5,481,128 9.52% 22,532,808 USD
MOLECULAR PARTNERS AG (MOLN) 817,397 2.53% 15,940,917 USD
MAUNA KEA TECHNOLOGIES (MKEA) 10,811,687 24.4% 9,405,735 USD
CRYO-CELL INTERNATIONAL, INC. (CCEL) 152,882 1.79% 1,773,431 USD
ALLIGATOR BIOSCIENCE AB (PUBL) (ATORX) 2,991,847 1.36% 849,894 USD
GRAIL, INC. 50,868,671 7.58% 509 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey

Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JOHNSON & JOHNSON-4.73%429 034
ROCHE HOLDING AG-9.06%304 714
PFIZER, INC.-12.72%289 287
ABBVIE INC.-2.39%233 643
ELI LILLY AND COMPANY-12.00%217 963
NOVO NORDISK A/S-17.16%210 749
MERCK & CO., INC.2.86%199 120
NOVARTIS AG-4.40%187 626
ASTRAZENECA PLC-4.17%173 383
BRISTOL-MYERS SQUIBB COMPANY0.42%138 972
AMGEN INC.0.49%127 343
SANOFI-0.07%125 716
GLAXOSMITHKLINE PLC0.50%109 325
BAYER AG6.38%55 573
CHUGAI PHARMACEUTICAL CO., LTD-1.15%53 303
TAKEDA PHARMACEUTICAL COMPANY LIMITED6.47%45 679
DAIICHI SANKYO CO., LTD.-11.13%43 749
JIANGSU HENGRUI MEDICINE CO., LTD.-15.56%43 570
ASTELLAS PHARMA INC.2.94%31 326
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-19.40%19 699
YUNNAN BAIYAO GROUP CO.,LTD-11.61%19 371